Title : The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.

Pub. Date : 2015 Jul

PMID : 25783974






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Early initiation of everolimus with calcineurin inhibitor therapy has been shown to reduce the progression of cardiac allograft vasculopathy (CAV) in de novo heart transplant recipients. Everolimus calcineurin binding protein 1 Homo sapiens
2 This 12-month multicenter Scandinavian trial randomized 115 de novo heart transplant recipients to everolimus with complete calcineurin inhibitor elimination 7-11 weeks after HTx or standard cyclosporine immunosuppression. Everolimus calcineurin binding protein 1 Homo sapiens